Further details on the partnership were kept confidential.
Avid Bioservices president Steven King said, "We are pleased to be working with Phage to offer their proprietary expression system, as it has many advantages and serves as an extension of our existing cGMP protein production services."
Phage Pharmaceuticals president and chief executive officer Jamie Oliver said Phage’s manufacturing process improves upon well-established approaches for the manufacture of targeted proteins and results in production of properly folded, soluble therapeutic proteins, at high yields.
Avid Bioservices provides a range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries to support manufacturing of cGMP commercial and clinical products.